caa a22 4500 445332433 CHVBK 20180317142741.0 cr unu---uuuuu 170323e20111001xx s 000 0 eng 10.1007/s10198-010-0266-y doi (NATIONALLICENCE)springer-10.1007/s10198-010-0266-y Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients [Elektronische Daten] [C. Sabariego, M. Brach, P. Herschbach, P. Berg, G. Stucki] Anxiety and fear are often associated with chronic conditions such as cancer. This paper targets the cost-effectiveness analysis of a cognitive-behavioral group therapy (CBT) in comparison to a client-centered, supportive-experiential group therapy (SET) in cancer patients with dysfunctional fear of progression. An incremental cost-effectiveness analysis was performed using data from a randomized controlled trial among cancer patients receiving inpatient rehabilitation. The means, 95% confidence intervals [95% CI], incremental cost-effectiveness graphic and acceptability curve were obtained from 1,000 bootstrap replications. A total of 174 patients were included in the economic evaluation. The estimated means [95% CI] of direct costs and reduction of fear of progression were €9,045.03 [6,359.07; 12,091.87] and 1.41 [0.93; 1.92] for patients in the SET and €6,682.78 [4,998.09; 8,440.95] and 1.44 [1.02; 1.09] for patients in the CBT. The incremental cost-effectiveness ratio [95% CI] amounts to minus €78,741.66 [−154,987.20; 110,486.32] for an additional unit of effect. Given the acceptability curve, there is a 92.4% chance that the CBT, compared with the SET, is cost-effective without the need of additional costs to payers. Our main result is the superior cost-effectiveness of the cognitive-behavioral intervention program in comparison to the non-directive encounter group for our sample of cancer patients with high levels of anxiety. Springer-Verlag, 2010 Cost-effectiveness nationallicence Cancer nationallicence Cognitive-behavioral therapy nationallicence Economic evaluation nationallicence Resource use nationallicence Sabariego C. Institute for Health and Rehabilitation Sciences, Ludwig-Maximilians-University, Marchioninistraße 17, 81377, Munich, Germany aut Brach M. Institute for Health and Rehabilitation Sciences, Ludwig-Maximilians-University, Marchioninistraße 17, 81377, Munich, Germany aut Herschbach P. Department and Outpatient Clinic of Psychosomatic Medicine and Psychotherapy, Division of Psychosocial Oncology, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany aut Berg P. Department and Outpatient Clinic of Psychosomatic Medicine and Psychotherapy, Division of Psychosocial Oncology, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany aut Stucki G. Swiss Paraplegic Research, Postfach CH-6207, Nottwil, Switzerland aut The European Journal of Health Economics Springer-Verlag 12/5(2011-10-01), 489-497 1618-7598 12:5<489 2011 12 10198 https://doi.org/10.1007/s10198-010-0266-y text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10198-010-0266-y text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Sabariego C. Institute for Health and Rehabilitation Sciences, Ludwig-Maximilians-University, Marchioninistraße 17, 81377, Munich, Germany aut NATIONALLICENCE 700 1- Brach M. Institute for Health and Rehabilitation Sciences, Ludwig-Maximilians-University, Marchioninistraße 17, 81377, Munich, Germany aut NATIONALLICENCE 700 1- Herschbach P. Department and Outpatient Clinic of Psychosomatic Medicine and Psychotherapy, Division of Psychosocial Oncology, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany aut NATIONALLICENCE 700 1- Berg P. Department and Outpatient Clinic of Psychosomatic Medicine and Psychotherapy, Division of Psychosocial Oncology, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany aut NATIONALLICENCE 700 1- Stucki G. Swiss Paraplegic Research, Postfach CH-6207, Nottwil, Switzerland aut NATIONALLICENCE 773 0- The European Journal of Health Economics Springer-Verlag 12/5(2011-10-01), 489-497 1618-7598 12:5<489 2011 12 10198 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer